Effect of concomitant diseases on the hemostasis system in the perioperative period of non-cardiac surgery

This study examined the effect of clinical factors and antithrombotic therapy on the blood coagulation system of patients in the perioperative period. The study included 80 patients who underwent elective noncardiac surgery. Laboratory control of hemostasis was carried out using routine tests for studying hemostasis (APTT, INR) and a global test for hemostasis (thrombodynamics test). Usage of the thrombodynamics test in this study was more sensitive compared to routine tests and made it possible to identify clinical factors associated with hypercoagulable states and «decreasing in the effectiveness» of low molecular weight heparins in the postoperative period. These factors are: age over 60 years, chronic ischemic heart disease, a history of coronary artery stenting, prior antithrombotic therapy before surgery. Hypercoagulability was found on the first day after surgery in patients with deep vein thrombosis of the lower extremities compared to other patients. The use of a thrombodynamics test a day before surgery allowed to predict an increase of intraoperative blood loss volume. Perioperative bridge therapy with low molecular weight heparins in high thrombotic risk patients was significantly associated with an increase in packed red blood cells transfusion of almost two times compared with other patients and is associated with an increased risk of hemorrhagic complications. The results of the study showed that thrombodynamics test can potentially be used further with the aim of personalizing patients’ management in the non-cardiac surgery perioperative period. It also helps to predict the occurrence of hemorrhagic and thrombotic complications.

1. Lyuboshevskiy P. A., Ovechkin A. M. Possibilities for assessment and correction of stress response in major surgery // Regionarnaya anesteziya i lechenie ostroy boli (Regional anesthesia and acute pain management) 2014; 8 (4): 5-21. In Russ.

2. Ovechkin A. M. Surgical stress-response, its pathophysiological significance and methods of modulation // Regionarnaya anesteziya i lechenie ostroy boli (Regional anesthesia and acute pain management) 2008; 2 (2): 49-62. In Russ.

3. Rodgers A., Walker N., Schug S. et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials // BMJ. 2000; 321 (7275): 1493.

4. Somonova O. V. Violation of the hemostasis system in cancer patients: Current state of the problem (literature review) // Vestnik RONTs im. N. N. Blokhina RAMN (Journal of N. N. Blokhin Russian Cancer Research Center RAMS). 2006; 17 (2). In Russ.

5. Khorana A. A., Francis C. W., Culakova E. et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients // Cancer: Interdisciplinary International Journal of the American Cancer Society. 2007; 110 (10): 2339-2346.

6. Grant P. J. Diabetes mellitus as a prothrombotic condition // Journal of internal medicine. 2007; 262.2: 157-172.

7. Petrik G. G., Pavlishchuk S. A., Kosmacheva E. D. Diabetes mellitus and cardiovascular complications: focus on hemostasis // Rossiiskii kardiologicheskii zhurnal (Russ J Cardiol). 2014; 3 (107): 114-118. In Russ.

8. Galyautdinov G. S., Chudakova E. A. Features of haemostasis in patients with coronary heart disease // Kazanskii meditsinskii zhurnal. (Kazan Medical Journal). 2012; 93 (1). In Russ.

9. Knuuti J., Wijns W., Saraste A., et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) // European Heart Journal. 2020; 41 (3): 407-477. DOI: 10.1093/eurheartj/ehz425.

10. Valgimigli M., Bueno H., Byrne R. A. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS // European journal of cardio-thoracic surgery. 2018; 39 (3): 213-260. DOI: 10.1093/eurheartj/ehx419.

11. Hindricks G. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC // European heart journal. 2021; 42 (5): 373-498.

12. Baumgartner H., Potpara T., Dagres N. et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease // European heart journal. 2017; 42 (5): 373-498. DOI: 10.1093/eurheartj/ehx391.

13. Pasechnik I. N., Berns S. A. Violation of hemostasis in surgical patients: a guide for physicians. Moscow: Geotar-media, 2021. 296 с. In Russ. DOI: 10.33029/9704-6395-6-HAE-2021-1-296.

14. Balandina A. N., Koltsova E. M., Shibeko A. M. et al. Thrombodynamics: a new method to the diagnosis of hemostasis system disorders // Voprosy gematologii/ onkologii i immunopatologii v pediatrii (Pediatric Hematology/Oncology and Immunopathology). 2018; 4 (17): 114-126. In Russ. DOI: 10.24287/1726-1708-2018-17-4-114-126.

15. Lipets E. N., Ataullakhanov F. I. Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk // Thromb J. 2015; 13 (1):1-15. DOI: 10.1186/s12959-015-0038-0.

16. Berns S. A., Shmidt E. A., Penskaya T. Y. et al. Thrombodynamics as a tool for monitoring the effectiveness of anticoagulant therapy in patients with pulmonary embolism // Kompleksnye problemy serdečno-sosudistyh zabolevanij (Complex Issues of Cardiovascular Diseases). 2020; 9 (4): 12-20. In Russ. DOI: 10.17802/2306-1278-2020-9-4-12-20.

17. Shlyk I. F. Informativeness of the thrombodynamic method in assessing the state of hemostasis in patients with coronary heart disease // Meditsinskii vestnik Yuga Rossii. Medical Herald of the South of Russia. 2019; 10 (2): 48-54. In Russ. https://doi.org/10.21886/2219-8075-2019-10-2-48-54.

18. Sinauridze E. I., Vuimo T. A., Tarandovskiy I. D. et al. Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency // Talanta. 2018; 180: 282-291. https://doi.org/10.1016/j.talanta.2017.12.055.

19. Balandina A. N., Serebriyskiy I. I., Poletaev A. V. et al. Thrombodynamics – A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment // PloS one. 2018; 13 (6): e0199900.